case_images: PMC5751898_01
case_images: Case 1 platelets and GFR.. Note. GFR = glomerular filtration rate.
case_images: 10.1177_2054358117747262-fig1.jpg
case_images: PMC5751898_01_10.1177_2054358117747262-fig1.jpg
case_images: fig1-2054358117747262
case_images: TTP. The platelet count began to increase after 2 days of treatment, normalized by day 10, and by day 14, there was normalization of the bilirubin and lactate dehydrogenase (LDH) (Figure 1).
case_images: PMC5751898_02
case_images: Case 2 platelets and GFR.. Note. GFR = glomerular filtration rate.
case_images: 10.1177_2054358117747262-fig2.jpg
case_images: PMC5751898_02_10.1177_2054358117747262-fig2.jpg
case_images: fig2-2054358117747262
case_images: Platelets normalized by day 16, and creatinine normalized by day 43 (Figure 2).
case_images: PMC5751898_03
case_images: Case 3 platelets and GFR.. Note. GFR = glomerular filtration rate.
case_images: 10.1177_2054358117747262-fig3.jpg
case_images: PMC5751898_03_10.1177_2054358117747262-fig3.jpg
case_images: fig3-2054358117747262
case_images: With a now documented improvement in kidney function, only requiring 4 total dialysis treatments, despite no antibodies found, rituximab continued weekly for 4 weeks (Figure 3).